VRCA - Insiders Buying Pfizer And 3 Other Stocks | Benzinga
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
Verrica Pharmaceuticals
- The Trade: Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) 10% owner Joseph Edelman acquired a total of 1,233,931 shares an average price of $5.63. To acquire these shares, it cost around $6.94 million.
- What’s Happening: Verrica Pharmaceuticals’ development and commercialization partner, Torii ...